ATTESTATTR-01TROCEPTcholangiocarcinomaurothelialendometrial
…eby increasing efficacy and reducing off-tumor toxicity.Methods ATTEST utilises a complex innovative design to explore dose, regimen, …
2articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: ATTEST ×
ATTEST
This institution is selected. Its supporting articles are shown below.
Articles mentioning ATTEST
2 articles · page 1 of 1ATTESTATTR-01TROCEPTepithelial cancers
…sitive non-clinical safety profile of ATTR-01. A phase 1 study, ATTEST, is evaluating safety and preliminary efficacy of intravenous d…